Filing Details
- Accession Number:
- 0001179110-20-000620
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-16 17:14:18
- Reporting Period:
- 2020-01-14
- Accepted Time:
- 2020-01-16 17:14:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1755118 | Ian Fier | C/O Momenta Pharmaceuticals, Inc. 301 Binney Street Cambridge MA 02142 | Chief Mfg And Program Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-14 | 8,466 | $12.58 | 9,648 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-14 | 33,010 | $13.02 | 42,658 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-14 | 4,031 | $15.44 | 46,689 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-14 | 26,521 | $17.96 | 73,210 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-14 | 15,675 | $18.85 | 88,885 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-14 | 46,227 | $25.00 | 42,658 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-14 | 41,476 | $22.00 | 1,182 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 7,055 | $0.00 | 7,055 | $12.58 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 1,411 | $0.00 | 1,411 | $12.58 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 6,712 | $0.00 | 6,712 | $13.02 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 26,298 | $0.00 | 26,298 | $13.02 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 3,976 | $0.00 | 3,976 | $15.44 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 55 | $0.00 | 55 | $15.44 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 7,449 | $0.00 | 7,449 | $17.96 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 19,072 | $0.00 | 19,072 | $17.96 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 8,312 | $0.00 | 8,312 | $18.85 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2020-01-14 | 7,363 | $0.00 | 7,363 | $18.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-02-19 | 2025-05-20 | No | 4 | M | Direct |
| 0 | 2015-11-19 | 2023-02-19 | No | 4 | M | Direct |
| 0 | 2019-02-18 | 2025-02-18 | No | 4 | M | Direct |
| 0 | 2018-11-18 | 2025-02-18 | No | 4 | M | Direct |
| 0 | 2016-02-14 | 2025-05-15 | No | 4 | M | Direct |
| 0 | 2015-11-14 | 2022-02-14 | No | 4 | M | Direct |
| 0 | 2018-02-18 | 2024-02-18 | No | 4 | M | Direct |
| 0 | 2017-11-18 | 2024-02-18 | No | 4 | M | Direct |
| 6,730 | 2019-11-07 | 2027-02-07 | No | 4 | M | Direct |
| 395 | 2019-11-07 | 2027-02-07 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan.
Billionaire Hedge Funds
